1Flavio Crippa,Ettore Seregni,Roberto Agresti,Carlo Chiesa,Claudio Pascali,Anna Bogni,Donatella Decise,Vinicio De Sanctis,Marco Greco,Maria Grazia Daidone,Emilio Bombardieri.Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation[J].European Journal of Nuclear Medicine.1998(10)
2Zhang DW,Zhang RG,Cheng GY.The surgical treatment of lung cancer: a retrospective analysis of 2004 cases[].Chinese Medical Journal.1999
3Mountain.CF Revisions in the international system for staging lung cancer[].Chest.1997
4Moldvay J,Scheid P,Wild P,et al.Predictive survival markers in patients with surgically resected non-small cell lung carcinoma[].Clinical Cancer Research.2000
5Depierre,A,Milleron,B,Moro-Sibilot,D,Chevret,S,Quoix,E,Lebeau,B.French Thoracic Cooperative Group. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1NO), II, and IIIa non-small-cell lung cancer[].Journal of Clinical Oncology.2002
6Roth JA,,Atkinson EN,Fossella F,et al.Long-term followup of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stageⅢA non-small-cell lung cancer[].Lung Cancer.1998
7Arriagada,R,Bergman,B,Dunant,A,Le,Chevalier,T,Pignon,JP,Vansteenkiste,J.Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer[].The New England Journal of Medicine.2004
8Fischer JR,Lahm H.Validation of molecular and immunological factors with predictive importance in lung cancer[].Lung Cancer.2004
9Pauwels,EK,Ribeiro,MJ,Stoot,JH,McCready,VR,Bourguignon,M,Maziere,B.FDG accumulation and tumor biology[].Nuclear Medicine and Biology.1998
10Phelps ME.Positron emission tomography provides molecular imaging of biological processes[].Proceedings of the National Academy of Sciences of the United States of America.2000
2Endo T,Yazawa T,Shishido-Hara Y,et al.Expression of developing neural transcription factors in lung carcinoid tumors[J].Pathol Int,2014,64(8):365-374.
3Sueta A,Yamamoto Y,Hayashi M,et al.Clinical significance of pretherapeutic Ki67 as a predictive parameter for response to neoadjuvant chemotherapy in breast cancer;is it equally useful across tumor subtypes[J].Surgery,2014,155(5):927-935.
4Berghoff AS,Ilhan-Mutlu A,Dinhof C,et al.Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type:analysis of 639 cases[J].Neuropathol Appl Neurobiol,2015,41(2):e41-e55.
5Bger C,Kalthoff H,Goodman SL,et al.Integrins and their ligands are expressed in non-small cell lung cancer but not correlated with parameters of disease progression[J].Virchows Archiv,2014,464(1):69-78.
6Berghoff AS,Kovanda AK,Melchardt T,et al.αvβ3,αvβ5 andαvβ6 integrins in brain metastases of lung cancer[J].Clin Exp Metastasis,2014,31(7):841-851.
7Claesson J,Freundlich M,Gunnarsson I,et al.Scandinavian clinical practice guideline on mechanical ventilation in adults with the acute respiratory distress syndrome cancer[J].Acta Anaesthesiol Scand,2015,59(3):286-297.
8Furukawa T,Miyata Y,Kushitani K,et al.Association between{18F}-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1αand glucose transporter 1 in non-small cell lung cancer[J].Jpn J Clin Oncol,2015,45(12):1154-1161.
9Granchi C,Qian Y,Lee HY,et al.Salicylketoximes that target glucose transporter 1 restrict energy supply to lung cancer cells[J].Chem Med Chem,2015,10(11):1892-1900.
10Tkés AM,Szász AM,Geszti F,et al.Expression of proliferation markers Ki67,cyclin A,geminin and aurora-kinase A in primary breast carcinomas and corresponding distant metastases[J].J Clin Pathol,2015,68(4):274-282.
